Showing results (281-290 of 582) with videos related to
Sort By:
Pageof 59
Bioorganic Chemistry|March 26, 2026
Discovery of orally bioavailable N-acylated remdesivir derivatives with potent broad-spectrum antiviral activityLetian Song, Bing Ye, Baohu Li, et al.Antiviral Research|January 27, 2022
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concernLaura Vangeel, Winston Chiu, Steven De Jonghe, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2025
The Indispensable Value of Small-Molecule Antivirals in Epidemic and Pandemic PreparednessRuxandra Draghia-Akli, Nina M Hill, Bruce Altevogt, et al.Journal of Medicinal Chemistry|October 24, 2007
Ester prodrugs of cyclic 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine: synthesis and antiviral activityMarcela Krecmerová, Antonín Holý, Radek Pohl, et al.Bioorganic & Medicinal Chemistry|October 6, 2014
Structure-activity relationship study of arbidol derivatives as inhibitors of chikungunya virus replicationAntonia Di Mola, Antonella Peduto, Annalisa La Gatta, et al.Journal of Natural Products|July 4, 2017
Isolation of Premyrsinane, Myrsinane, and Tigliane Diterpenoids from Euphorbia pithyusa Using a Chikungunya Virus Cell-Based Assay and Analogue Annotation by Molecular NetworkingMélissa Esposito, Louis-Félix Nothias, Pascal Retailleau, et al.Journal of Medicinal Chemistry|February 15, 2007
Antiviral activity of triazine analogues of 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine (cidofovir) and related compoundsMarcela Krecmerová, Antonín Holý, Alois Pískala, et al.Bioorganic & Medicinal Chemistry Letters|June 21, 2011
SAR studies of 9-norbornylpurines as Coxsackievirus B3 inhibitorsMichal Sála, Armando M De Palma, Hubert Hřebabecký, et al.Journal of Virology|August 27, 2010
Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencingThierry Verbinnen, Herwig Van Marck, Ina Vandenbroucke, et al.Bioorganic & Medicinal Chemistry|May 11, 2016
Discovery of pyrazinone based compounds that potently inhibit the drug-resistant enzyme variant R155K of the hepatitis C virus NS3 proteaseAnna Karin Belfrage, Eldar Abdurakhmanov, Eva Kerblom, et al.Pageof 59